
No. of Pages: 114 | Report Code: BMIRE00025331 | Category: Life Sciences
No. of Pages: 114 | Report Code: BMIRE00025331 | Category: Life Sciences
Table of Content
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 South & Central America Infectious Disease Diagnostics Market, by Country (US$ Million)
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Infectious Disease Diagnostics Market - Key Industry Dynamics
4.1 Market Drivers:
4.1.1 Rising Incidence of Infectious Diseases
4.1.2 Rising Application of Diagnostics in Veterinary Infectious Disease
4.2 Market Restraints
4.2.1 Inadequate Reimbursement Scenario
4.3 Market Opportunities
4.3.1 Increasing Focus on R&D and Funding in Infectious Disease Diagnostics
4.4 Future Trends
4.4.1 Rising Number of Product Approvals and Launches
4.5 Impact Analysis:
5. Infectious Disease Diagnostics Market - South & Central America Market Analysis
5.1 South & Central America Infectious Disease Diagnostics Market Revenue (US$ Mn), 2022 - 2030
6. South & Central America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by Product
6.1 Overview
6.2 South & Central America Infectious Disease Diagnostics Market Revenue Share, by Product, 2022 & 2030 (%)
6.3 Kits & Reagents
6.3.1 Overview
6.3.2 Kits & Reagents: South & Central America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Instruments
6.4.1 Overview
6.4.2 Instruments: South & Central America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Software & Services
6.5.1 Overview
6.5.2 Software & Services: South & Central America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7. South & Central America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by Technology
7.1 Overview
7.2 South & Central America Infectious Disease Diagnostics Market Revenue Share, by Technology, 2022 & 2030 (%)
7.3 Biosensor-based
7.3.1 Overview
7.3.2 Biosensor-based: South & Central America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Immunodiagnostics
7.4.1 Overview
7.4.2 Immunodiagnostics: South & Central America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.4.2.1 South & Central America Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million)
7.5 Molecular-Based Diagnostic Techniques
7.5.1 Overview
7.5.2 Molecular-Based Diagnostic Techniques: South & Central America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.5.2.1 South & Central America Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million)
7.6 Clinical Biology
7.6.1 Overview
7.6.2 Clinical Biology: South & Central America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: South & Central America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8. South & Central America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by Application Type
8.1 Overview
8.2 South & Central America Infectious Disease Diagnostics Market Revenue Share, by Application Type, 2022 & 2030 (%)
8.3 Point-of-Care Testing
8.3.1 Overview
8.3.2 Point-of-Care Testing: South & Central America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Laboratory Testing
8.4.1 Overview
8.4.2 Laboratory Testing: South & Central America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
9. South & Central America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by Testing Type
9.1 Overview
9.2 South & Central America Infectious Disease Diagnostics Market Revenue Share, by Testing Type, 2022 & 2030 (%)
9.3 Human Testing
9.3.1 Overview
9.3.2 Human Testing: South & Central America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
9.3.2.1 South & Central America Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million)
9.4 Veterinary Testing
9.4.1 Overview
9.4.2 Veterinary Testing: South & Central America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10. South & Central America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by End User
10.1 Overview
10.2 South & Central America Infectious Disease Diagnostics Market Revenue Share, by End User, 2022 & 2030 (%)
10.3 Diagnostic Laboratories
10.3.1 Overview
10.3.2 Diagnostic Laboratories: South & Central America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Hospitals and Clinics
10.4.1 Overview
10.4.2 Hospitals and Clinics: South & Central America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.5 Research Institutes
10.5.1 Overview
10.5.2 Research Institutes: South & Central America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.6 Homecare Settings
10.6.1 Overview
10.6.2 Homecare Settings: South & Central America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.7 Others
10.7.1 Overview
10.7.2 Others: South & Central America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11. South & Central America Infectious Disease Diagnostics Market - Country Analysis
11.1 South & Central America Infectious Disease Diagnostics Market - Country Analysis
11.1.1 South & Central America Infectious Disease Diagnostics Market, by Country
11.1.1.1 Brazil
11.1.1.1.1 Overview
11.1.1.1.2 Brazil: South & Central America Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.1.3 Brazil: South & Central America Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million)
11.1.1.1.4 Brazil: South & Central America Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million)
11.1.1.1.4.1 Brazil: South & Central America Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million)
11.1.1.1.4.2 Brazil: South & Central America Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million)
11.1.1.1.5 Brazil: South & Central America Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million)
11.1.1.1.6 Brazil: South & Central America Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million)
11.1.1.1.6.1 Brazil: South & Central America Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million)
11.1.1.1.7 Brazil: South & Central America Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million)
11.1.1.2 Argentina
11.1.1.2.1 Overview
11.1.1.2.2 Argentina: South & Central America Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.2.3 Argentina: South & Central America Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million)
11.1.1.2.4 Argentina: South & Central America Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million)
11.1.1.2.4.1 Argentina: South & Central America Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million)
11.1.1.2.4.2 Argentina: South & Central America Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million)
11.1.1.2.5 Argentina: South & Central America Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million)
11.1.1.2.6 Argentina: South & Central America Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million)
11.1.1.2.6.1 Argentina: South & Central America Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million)
11.1.1.2.7 Argentina: South & Central America Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million)
11.1.1.3 Rest of South & Central America
11.1.1.3.1 Overview
11.1.1.3.2 Rest of South & Central America: South & Central America Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.3.3 Rest of South & Central America: South & Central America Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million)
11.1.1.3.4 Rest of South & Central America: South & Central America Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million)
11.1.1.3.4.1 Rest of South & Central America: South & Central America Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million)
11.1.1.3.4.2 Rest of South & Central America: South & Central America Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million)
11.1.1.3.5 Rest of South & Central America: South & Central America Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million)
11.1.1.3.6 Rest of South & Central America: South & Central America Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million)
11.1.1.3.6.1 Rest of South & Central America: South & Central America Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million)
11.1.1.3.7 Rest of South & Central America: South & Central America Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million)
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 Abbott Laboratories
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Bruker Corp
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Cardinal Health Inc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 F. Hoffmann-La Roche Ltd
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Trinity Biotech Plc
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Danaher Corp
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Bio-Rad Laboratories Inc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 ACON Laboratories Inc
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 DiaSorin SpA
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
14. Appendix
14.1 About Us
14.2 Glossary of Terms
List of Tables
Table 1. South & Central America Infectious Disease Diagnostics Market Segmentation
Table 2. South & Central America Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 3. South & Central America Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 4. South & Central America Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million)
Table 5. Brazil: South & Central America Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 6. Brazil: South & Central America Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 7. Brazil: South & Central America Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 8. Brazil: South & Central America Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 9. Brazil: South & Central America Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million)
Table 10. Brazil: South & Central America Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million)
Table 11. Brazil: South & Central America Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million)
Table 12. Brazil: South & Central America Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 13. Argentina: South & Central America Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 14. Argentina: South & Central America Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 15. Argentina: South & Central America Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 16. Argentina: South & Central America Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 17. Argentina South & Central America Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million)
Table 18. Argentina: South & Central America Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million)
Table 19. Argentina: South & Central America Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million)
Table 20. Argentina: South & Central America Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 21. Rest of South & Central America: South & Central America Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 22. Rest of South & Central America: South & Central America Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 23. Rest of South & Central America: South & Central America Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 24. Rest of South & Central America: South & Central America Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 25. Rest of South & Central America: South & Central America Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million)
Table 26. Rest of South & Central America Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million)
Table 27. Rest of South & Central America: South & Central America Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million)
Table 28. Rest of South & Central America: South & Central America Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 29. Organic Developments Done By Companies
Table 30. Inorganic Developments Done By Companies
Table 31. Glossary of Terms, South & Central America Infectious Disease Diagnostics Market
List of Figures
Figure 1. South & Central America Infectious Disease Diagnostics Market Segmentation, By Country
Figure 2. South & Central America Infectious Disease Diagnostics Market - Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. South & Central America Infectious Disease Diagnostics Market Revenue (US$ Mn), 2022 - 2030
Figure 5. South & Central America Infectious Disease Diagnostics Market Revenue Share, by Product, 2022 & 2030 (%)
Figure 6. Kits & Reagents: South & Central America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Instruments: South & Central America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Software & Services: South & Central America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. South & Central America Infectious Disease Diagnostics Market Revenue Share, by Technology, 2022 & 2030 (%)
Figure 10. Biosensor-based: South & Central America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Immunodiagnostics: South & Central America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Molecular-Based Diagnostic Techniques: South & Central America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Clinical Biology: South & Central America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: South & Central America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. South & Central America Infectious Disease Diagnostics Market Revenue Share, by Application Type, 2022 & 2030 (%)
Figure 16. Point-of-Care Testing: South & Central America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Laboratory Testing: South & Central America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. South & Central America Infectious Disease Diagnostics Market Revenue Share, by Testing Type, 2022 & 2030 (%)
Figure 19. Human Testing: South & Central America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Veterinary Testing: South & Central America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. South & Central America Infectious Disease Diagnostics Market Revenue Share, by End User, 2022 & 2030 (%)
Figure 22. Diagnostic Laboratories: South & Central America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Hospitals and Clinics: South & Central America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Research Institutes: South & Central America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Homecare Settings: South & Central America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Others: South & Central America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. South & Central America Infectious Disease Diagnostics Market, by Key Country - Revenue, 2022 (US$ Million)
Figure 28. South & Central America Infectious Disease Diagnostics Market, By Key Countries, 2022 and 2030 (%)
Figure 29. Brazil: South & Central America Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 30. Argentina: South & Central America Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 31. Rest of South & Central America: South & Central America Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 32. Growth Strategies Done by the Companies in the Market, (%)
1. Abbott Laboratories
2. Bruker Corp
3. Cardinal Health Inc
4. F. Hoffmann-La Roche Ltd
5. Trinity Biotech Plc
6. Danaher Corp
7. Bio-Rad Laboratories Inc
8. ACON Laboratories Inc
9. DiaSorin SpA